BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Cesar Millan helps Avivagen Relaunch Vivamune Health Chews in U.S.

  At the heart of Vivamune is an active substance, called OxC-beta (OxC-beta) compound, Avivagen’s proprietary formulation of fully oxidized β-carotene.

  October 23, 2017

   · 

  6 min read
• Business

  Recipharm Equips Lisbon Facility for US and European Serialisation

  Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped its sixth facility with serialisation capabilities ahead of the US and European regulation enforcement deadlines.

  October 23, 2017

   · 

  3 min read
• 

  FDA

  K2M Acquires World’s First & Only FDA-Cleared Cervical Static Corpectomy Cage

  Research supporting favorable findings on the PALO ALTO Cervical Static Corpectomy Cage System to be presented at NASS 2017.

  October 23, 2017

   · 

  9 min read
• Evonik Increases Prices for Potassium Methylate 32% Solution in Methanol

  Evonik Performance Materials GmbH announces a global price increase for its Potassium Methylate solution alkoxide, effective from November 1, 2017.

  October 23, 2017

   · 

  1 min read
• Business

  Jounce Therapeutics Appoints Luis A. Diaz, Jr., M.D., to its Board of Directors

  Dr. Diaz brings to the company his world-renowned expertise in cancer genetics and a precision medicine approach to immuno-oncology.

  October 23, 2017

   · 

  4 min read
• Drug Development

  Achillion Announces Presentation of Data From OMEGA-1 Phase IIb Trial With Odalasvir, AL-335, and Simeprevir (JNJ-4178) at the 2017 Liver Meeting

  98.9% SVR12 achieved following six weeks of therapy for patients with chronic HCV genotypes 1, 2, 4, 5, or 6.

  October 23, 2017

   · 

  4 min read
• Bio NC

  RedHill Biopharma Receives Notice of Allowance for a New U.S. Patent Covering RHB-104

  RHB-104 is a proprietary, orally-administered, potentially ground-breaking, antibiotic combination therapy with potent intracellular, antimycobacterial and anti-inflammatory properties.

  October 23, 2017

   · 

  9 min read
• Drug Development

  Ergomed’s First-in-Class Haemostat, Peprostat, Reports Positive Top-Line Results and Meets Key Endpoints in Phase II Study

  Ergomed plc announces positive top-line results from its Phase II clinical trial of PeproStat, the Company’s potential first-in-class coagulant, or ‘haemostat’, for intraoperative surgical bleeding.

  October 23, 2017

   · 

  6 min read
• Drug Development

  Madrigal Pharmaceuticals Presents Preclinical Results Supporting the Therapeutic Potential of its Lead β-Selective Thyroid Hormone Receptor Agonist, MGL-3196, at AASLD Liver Meeting

  Results demonstrate that mgl-3196 provides metabolic, anti-inflammatory and anti-fibrotic benefits in a long-term, high fat diet, mouse NASH model.

  October 23, 2017

   · 

  3 min read
• Business

  Collaborative Clinical Study Aims to Advance Treatment of Kidney and Prostate Cancer with 3D Printing

  Stratasys announced a new clinical study is being conducted with the New York University (NYU) School of Medicine – aimed at advancing diagnosis and treatment of complex kidney and prostate tumors through imaging and 3D printing.

  October 23, 2017

   · 

  5 min read